Navigation For Mobile

Monthly Archives: December 2014

Neuland Labs: Spotlight on Hypertension

Cardiovascular (heart) disease is one of Neuland’s core therapeutic areas, with multiple Neuland products in the space. It’s also the leading cause of death worldwide, and (sadly…for the sake of…

Posted in cardiovascular disease, drugs, hypertension, Neuland Labs | Comments Off on Neuland Labs: Spotlight on Hypertension

You Can’t Keep a Good Drug Down

Reducing Mutagens, Carcinogens & Other Genotoxins to Improve Safety Profiles There are a number of process modifications API manufacturers can make to improve safety profiles, reduce production costs, improve capacity…

Posted in analytical science, APIs, Capabilities, Chemistry, CMC, Contract Manufacturing, critical reaction parameters, CRO/CMO, drugs, EHS, genotoxic impurities, green chemistry, method development, Neuland Labs, QA/QC, QbD, R&D, regulatory, Route Design, scale-up, Synthesis Route, zero liquid discharge | Comments Off on You Can’t Keep a Good Drug Down